On May 9, 2024, Eli Lilly and Company announced that it held its annual general meeting of shareholders on May 6, 2024, and declared voting results. Accordingly, a shareholder proposal from Trinity Health, requesting to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents was not approved.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
815.1 USD | +1.52% | +6.17% | +40.45% |
03:59pm | Jefferies Adjusts Price Target on Eli Lilly to $925 From $915 | MT |
06:58am | Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.89% | 723B | |
+34.28% | 595B | |
-3.70% | 369B | |
+20.27% | 332B | |
+2.85% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.02% | 168B | |
+7.39% | 166B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Declaration of Voting Results by Eli Lilly and Company